Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ningmitai Capsule for Residual Fragments After Ureteroscopic Lithotripsy
NCT06105827Phase 4Completed
- Sponsor
- Guiyang Xintian Pharmaceutical Co., Ltd.
- Start
- Oct 2016
- Primary completion
- Apr 2019
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of Ningmitai Capsule in ureteral calculus (3 arms), sponsored by Guiyang Xintian Pharmaceutical Co., Ltd. Primary endpoints: Stone expulsion time at 12 weeks and Stone-free time at 12 weeks. Started Oct 2016; status: completed.
02
Drugs
Ningmitai Capsule
03
Conditions
ureteral calculus
Beyond the preview
Go deeper on NCT06105827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06105827.